News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
FDA and UK regulator appoint liaison officers to align device and AI oversight
The FDA and MHRA are formalizing collaboration through reciprocal liaison roles. The focus: medical devices, AI, and innovative medicines—with the goal of faster approvals and reduced friction for companies operating on both sides of the Atlantic.
AvenCell's Switchable CAR-T Shows Early Signal in Hard-to-Treat AML
AvenCell presented Phase 1a data for AVC-201-01, an allogeneic CAR-T therapy with a pharmacological on-off switch, treating relapsed AML patients with manageable safety and early efficacy signals.
Late-stage gene therapy CDMOs face three crushing risks before FDA approval
Viral vector manufacturers must overcome regulatory gaps, tech transfer failures, and market volatility to reach patients. Here's where 90+ programs stumbled and what CDMOs now demand.
Moderna's Flu Shot Blocks More Virus Strains Than Standard Vaccine
An mRNA flu vaccine produced broader antibody responses and cut illness risk 26.6% more than traditional shots in older adults. A Nature Immunology study reveals why.
Five Process Design Gaps That Trap Purification Bottlenecks in Biotech
Downstream purification failures often trace to upstream planning oversights: single-source materials, wrong pack sizes, fragile buffers, and single-use systems without realistic failure modes. GEN webinar shows how to spot and fix them.
Silica Nanoparticles Kill Prostate Tumors, Unlock Checkpoint Blockade in Mice
Weill Cornell researchers report that targeted silica nanoparticles triggered ferroptosis and immune remodeling, enabling 40-50% complete remissions when combined with immunotherapy in preclinical models.
UCSF maps 9 drug targets that kill therapy-resistant cancer cells
Researchers screened 94 drugs against persister cells using a robotic platform and identified shared vulnerabilities. The dataset is now open to the research community.
Three European Biotech Startups Target $400B Wound Care Crisis at BioTrinity 2026
BioTrinity 2026 showcased delivery tech and clinical candidates from Renovos, Onya, StemSight, and Link Biologics. Read what each company is building and when trials start.
Lilly signs GLP-2 deal with Hanmi, expands obesity drug portfolio beyond weight loss
Eli Lilly inked a GLP-2 licensing agreement with Hanmi Pharmaceutical to broaden its GLP franchise into gastrointestinal disease treatment, moving beyond the weight-loss market that dominates current revenue.
G7 faces July 17 deadline to finish pandemic treaty, WHO warns
WHO chief Tedros and Brazil's Lula demand G7 leaders finalize a treaty annex on pathogen sharing by mid-July. Without it, the world remains unprepared for the next outbreak.
Modi leads Yoga Day in Kolkata; 2,500 global events planned
Prime Minister Narendra Modi will headline the International Day of Yoga on June 21 in Kolkata. India's Ayush ministry is coordinating 210 missions abroad to run yoga events worldwide, with this year's focus on healthy aging.
Your brain's protein signature predicts death risk 10 years early
Stanford researchers used blood plasma proteins to measure organ age across 11 systems. An extremely aged brain increased mortality risk by 182% over 15 years; a youthful one cut it by 40%.